Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties

被引:16
作者
Ahn, Gang [1 ]
Lansiaux, Amelie [3 ,4 ]
Goossens, Jean-Francois [6 ]
Bailly, Christian [5 ]
Baldeyrou, Brigitte [3 ,4 ]
Schifano-Faux, Nadege [6 ]
Grandclaudon, Pierre [1 ,2 ]
Couture, Axel [1 ]
Ryckebusch, Adina [1 ,2 ]
机构
[1] Univ Lille 1, Univ Lille Nord France, EA CMF 4478, F-59655 Villeneuve Dascq, France
[2] ENSCL, F-59652 Villeneuve Dascq, France
[3] Univ Lille 2, Univ Lille Nord France, INSERM, Ctr Oscar Lambret,IRCL,U837, F-59045 Lille, France
[4] IMPRT, F-59045 Lille, France
[5] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, F-31140 Toulouse, France
[6] Univ Lille 2, Univ Lille Nord France, Chim Analyt Lab, EA 4481, F-59006 Lille, France
关键词
Cancer; DNA ligand; Topoisomerases; Cytotoxicity; Amino acid conjugate; Indenoisoquinolin-5,11-dione; NITRATED INDENOISOQUINOLINES; ANTICANCER ACTIVITY; ANTITUMOR-ACTIVITY; BINDING; AGENTS; CAMPTOTHECINS; INTERCALATORS; OPTIMIZATION; PERSPECTIVES; RELAXATION;
D O I
10.1016/j.bmc.2010.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n = 2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n = 3 provided the highest DNA binding. Arginine derivative 32 (n = 2, series II) and glycine derivative 34 (n = 2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC50 values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC50 values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8119 / 8133
页数:15
相关论文
共 35 条
[1]  
*ADV CHEM DEV INC, PKA LOG D VAL WER CA
[2]   Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity [J].
Antony, Smitha ;
Agama, Keli K. ;
Miao, Ze-Hong ;
Hollingshead, Melinda ;
Holbeck, Susan L. ;
Wright, Mollie H. ;
Varticovski, Lyuba ;
Nagarajan, Muthukaman ;
Morrell, Andrew ;
Cushman, Mark ;
Pommier, Yves .
MOLECULAR PHARMACOLOGY, 2006, 70 (03) :1109-1120
[3]   POTENTIAL ANTI-TUMOR AGENTS .34. QUANTITATIVE RELATIONSHIPS BETWEEN DNA-BINDING AND MOLECULAR-STRUCTURE FOR 9-ANILINOACRIDINES SUBSTITUTED IN THE ANILINO RING [J].
BAGULEY, BC ;
DENNY, WA ;
ATWELL, GJ ;
CAIN, BF .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (02) :170-177
[4]  
Bailly C, 2001, METHOD ENZYMOL, V340, P610
[5]   Structural studies of type I topoisomerases [J].
Baker, Nicole M. ;
Rajan, Rakhi ;
Mondragon, Alfonso .
NUCLEIC ACIDS RESEARCH, 2009, 37 (03) :693-701
[6]   The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing [J].
Deweese, Joseph E. ;
Osheroff, Neil .
NUCLEIC ACIDS RESEARCH, 2009, 37 (03) :738-748
[7]   Oxoazabenzo[de]anthracenes conjugated to amino acids:: Synthesis and evaluation as DNA-binding antitumor agents [J].
Dias, N ;
Goossens, JF ;
Baldeyrou, B ;
Lansiaux, A ;
Colson, P ;
Di Salvo, A ;
Bernal, J ;
Turnbull, A ;
Mincher, DJ ;
Bailly, C .
BIOCONJUGATE CHEMISTRY, 2005, 16 (04) :949-958
[8]   Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms [J].
Forterre, Patrick ;
Gadelle, Daniele .
NUCLEIC ACIDS RESEARCH, 2009, 37 (03) :679-692
[9]   Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[10]  
HARKER WG, 1995, CANCER RES, V55, P1707